The antidepressant-like effects of Danggui Buxue Decoction in GK rats by activating CREB/BDNF/TrkB signaling pathway

Phytomedicine. 2021 Aug:89:153600. doi: 10.1016/j.phymed.2021.153600. Epub 2021 May 21.

Abstract

Background: High rates of co-morbidity have been reported in patients with diabetes mellitus with depression (DD). Danggui Buxue Decoction (DBD), a Traditional Chinese Medicine formula composed of Angelica and Astragalus, has been historically used for the treatment of diabetes.

Purpose: This study aimed to investigated whether DBD and its main active component, ferulic acid (FA) from Angelica, could ameliorate depression-like behavior in DD and the underlying mechanisms.

Methods: Goto-Kakizaki (GK) rats were administered DBD (4 or 8 g/kg) by oral gavage during a 4-week period of chronic unpredictable mild stress. After 4 weeks, blood glucose, glycated serum protein, serum insulin, oral glucose tolerance and depression-like behavior were examined, along with brain-derived neurotrophic factor (BDNF)-related signaling pathway proteins and the ultrastructure of hippocampal tissues. UPLC-QTOF-MS was adopted to detect the absorption of FA in the serum and hippocampus. Rat primary hippocampal cells were cultured in a DD model. Protein and mRNA levels of genes involved in BDNF-related signaling and neuroplasticity were analyzed.

Results: DBD effectively improved glucose tolerance in DD rats and relieved depression-like behavior. Upregulation of cAMP response element binding protein (CREB), BDNF, and tropomyosin receptor kinase B (TrkB) and improvement of the hippocampal neuron ultrastructure supported the antidepressant-Like effects of DBD on the hippocampal neurons. In addition, DBD enhanced the protein and mRNA levels of components of the CREB/BDNF/TrkB pathway in rat primary hippocampal cells induced by elevated glycemia and cortisol. Interestingly, FA, the main component of DBD absorbed in the blood and hippocampus, showed similar effects as DBD on primary hippocampal cells.

Conclusion: This study suggests that the TCM formula DBD effectively serves as a potential therapeutic agent for prevention of DD through regulatory effects on the CREB/BDNF/TrkB pathway to protect and remodel hippocampal neurons. Moreover, FA contributes significantly to the treatment effects of DBD.

Keywords: CREB/BDNF/TrkB pathway; Danggui Buxue Decoction; Depression; Diabetes mellitus; Ferulic acid; Neuronal protection.

MeSH terms

  • Animals
  • Antidepressive Agents* / pharmacology
  • Brain-Derived Neurotrophic Factor* / metabolism
  • Cells, Cultured
  • Cyclic AMP Response Element-Binding Protein* / metabolism
  • Drugs, Chinese Herbal / pharmacology*
  • Hippocampus / cytology
  • Hippocampus / metabolism
  • Neurons / drug effects
  • Neurons / ultrastructure
  • Rats
  • Receptor, trkB* / metabolism
  • Receptor, trkB* / pharmacology
  • Signal Transduction / drug effects

Substances

  • Antidepressive Agents
  • Brain-Derived Neurotrophic Factor
  • Cyclic AMP Response Element-Binding Protein
  • Drugs, Chinese Herbal
  • danggui buxue decoction
  • Receptor, trkB